Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome

Brain tumors represent a rare and relatively uncharacterized tumor type in Lynch syndrome.

[1]  A. Duval,et al.  Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD) , 2014, Journal of Medical Genetics.

[2]  A. Duval,et al.  Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D) , 2014, Journal of Medical Genetics.

[3]  H. Peeters,et al.  Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency , 2013, Genes, chromosomes & cancer.

[4]  J. A. Heath,et al.  Anaplastic oligodendroglioma in an adolescent with Lynch syndrome , 2013, Pediatric blood & cancer.

[5]  B. Lembersky,et al.  Simultaneous Muir-Torre and Turcot's syndrome: A case report and review of the literature , 2013, Surgical neurology international.

[6]  R. Kleinerman,et al.  Muir-Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma. , 2012, Dermatology online journal.

[7]  Zev A. Binder,et al.  Glioblastoma multiforme in the Muir–Torre syndrome , 2011, Clinical Neurology and Neurosurgery.

[8]  S. Gallinger,et al.  Oncologic surveillance for subjects with biallelic mismatch repair gene mutations-10 year follow-up in a kindred , 2011, Hereditary Cancer in Clinical Practice.

[9]  K. Wimmer,et al.  Constitutional mismatch repair-deficiency syndrome , 2010, Haematologica.

[10]  Deric M. Park,et al.  Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme. , 2009, Neuro-oncology.

[11]  P. Hui,et al.  Anaplastic oligoastrocytoma in Turcot syndrome , 2009, Journal of Neuro-Oncology.

[12]  D. Evans,et al.  Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations , 2009, Clinical genetics.

[13]  I. Bernstein,et al.  Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum , 2009, Familial Cancer.

[14]  K. Wimmer,et al.  Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? , 2008, Human Genetics.

[15]  J. Mecklin,et al.  The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome , 2008, International journal of cancer.

[16]  P. Peltomäki,et al.  Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors. , 2008, Carcinogenesis.

[17]  C. Watling,et al.  Glioblastoma in a Patient with a Hereditary Cancer Syndrome , 2008, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[18]  S. Boué,et al.  Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1 , 2008, European Journal of Human Genetics.

[19]  J. Østergaard,et al.  Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6 , 2005, American journal of medical genetics. Part A.

[20]  H. Morreau,et al.  Two PMS2 Mutations in a Turcot Syndrome Family with Small Bowel Cancers , 2005, The American Journal of Gastroenterology.

[21]  C. Richards,et al.  A Homozygous Mutation in MSH6 Causes Turcot Syndrome , 2005, Clinical Cancer Research.

[22]  T. Shiraishi,et al.  Molecular analysis of astrocytoma associated with Turcot syndrome type 1--case report. , 2004, Neurologia medico-chirurgica.

[23]  G. Petersen,et al.  Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC? , 2001, Familial Cancer.

[24]  M. Hennerici,et al.  Glioblastoma multiforme als Manifestation des Turcot-Syndroms , 2002, Der Nervenarzt.

[25]  J. Gebert,et al.  [Glioblastoma multiforme as a manifestation of Turcot syndrome]. , 2002, Der Nervenarzt.

[26]  P. Møller,et al.  MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  A. Iannelli,et al.  Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene , 2000, Oncogene.

[28]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[29]  L. Aaltonen,et al.  Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.

[30]  S. Leung,et al.  Microsatellite instability and mutation of DNA mismatch repair genes in gliomas. , 1998, The American journal of pathology.

[31]  Erwin G. Van Meir,et al.  Brain tumor-polyposis syndrome: two genetic diseases? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. Kleibeuker,et al.  The risk of brain tumours in hereditary non‐polyposis colorectal cancer (HNPCC) , 1996, International journal of cancer.

[33]  K. Kinzler,et al.  The molecular basis of Turcot's syndrome. , 1995, The New England journal of medicine.

[34]  A. Auvinen,et al.  Malignant Tumors of the Central Nervous System , 2020, Occupational Cancers.